Ontology highlight
ABSTRACT:
SUBMITTER: Goodman K
PROVIDER: S-EPMC10277169 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature
Goodman Kent K Abel Mary Kathryn MK Lawhn-Heath Courtney C Molina-Vega Julissa J Jones Ella F EF Mukhtar Rita A RA
Surgical oncology clinics of North America 20221001 4
<sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) is a Food and Drug Administration-approved radiopharmaceutical used for molecular imaging of the estrogen receptor (ER). When combined with PET, <sup>18</sup>F-FES may improve the diagnosis of ER-positive breast cancer in the metastatic setting and provide insights into tumor heterogeneity. In this article, we review data on the use of <sup>18</sup>F-FES imaging for treatment selection, staging, imaging lobular breast cancer, and the novel brea ...[more]